文献速递鼻科

囊性纤维化患者功能性内镜鼻窦手术的临床结局——单中心经验

Clinical outcomes of functional endoscopic sinus surgery in cystic fibrosis patients - a single centre experience.
PubMed 文献 · Rhinology · 2024-01-01

单中心回顾性研究纳入2015至2021年接受内镜鼻窦手术的55例囊性纤维化患者,术后1年肺功能显著改善,术后6个月SNOT-22评分达最小临床重要差异降幅,但肺移植组及既往鼻窦手术组无肺功能改善,肺急性加重率无变化。

要点

  • 囊性纤维化患者内镜鼻窦术后6个月SNOT-22评分较术前下降达最小临床重要差异(9分)。
  • 术后1年肺功能(FEV1占预计值%)显著改善,但肺移植及既往鼻窦手术者无改善。
  • 术后肺急性加重(静脉抗生素总天数)无变化,队列中2例死于肺部疾病。

核心结论

  • 本研究显示内镜鼻窦手术在囊性纤维化患者中具有临床和症状获益。
  • 作者认为未来需针对将接受内镜鼻窦手术的囊性纤维化患者建立更严格的手术指征指南。

研究设计与样本

  • 单中心回顾性研究,纳入2015至2021年六年期间接受内镜鼻窦手术的16岁以上囊性纤维化患者(含肺移植与非移植者)。
  • 排除使用三联疗法CFTR调节剂的患者,共纳入55例,中位年龄31岁,女性占53%。

主要发现

  • 队列中位Lund-Mackay评分为13(范围3-24)。
  • 术后1年肺功能(FEV1占预计值%)显著改善,术后6个月SNOT-22评分较术前下降达最小临床重要差异(9分)。
  • 亚组分析显示肺移植组与自体肺组、首次内镜鼻窦手术组与既往内镜鼻窦手术组的SNOT-22评分均持续下降达最小临床重要差异。
  • 肺移植患者及既往内镜鼻窦手术患者术后肺功能无改善。
  • 队列整体肺急性加重率(静脉抗生素总天数,含门诊与住院)无变化,2例患者死于肺部疾病。

关键数值与推荐

  • SNOT-22评分采用最小临床重要差异为9分。
  • 客观结局指标为肺功能(FEV1占预计值%)和肺急性加重(静脉抗生素总天数,含门诊与住院)。
  • 主观结局指标为术前与术后6个月SNOT-22评分。

临床怎么用

  • 原文未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endoscopic sinus surgery (ESS) is an established surgical option for cystic fibrosis (CF) patients with chronic rhinosinusitis that is refractory to conventional medical management. Objective and subjective evidence of benefit of ESS in this cohort of patients is currently conflicting in the literature. METHODOLOGY: A single center retrospective study was undertaken of all CF patients (transplanted and non-transplanted) over the age of 16 who underwent an ESS over a six-year period from 2015 to 2021. Patients on triple-therapy CFTR modulators were excluded. Data was collected on demographics, clinical management, and outcome measures. The objective outcome measures were lung function (%predicted FEV1), pulmonary exacerbations (total number of days of IV antibiotics- both ambulatory and in hospital). The subjective outcome measure was SNOT-22 scores pre and 6 months post-operatively. A minimally clinical important difference (MCID) in SNOT-22 scores of 9 points was used. RESULTS: 55 patients were included in our study, with a median age of 31 and 53% females. Median Lund-Mackay scores for the cohort was 13 (3-24). There was a significant improvement in lung function at 1-year post-surgery, and a significant MCID reduction in SNOT-22 scores at 6 months post-surgery across the cohort. Sub-group analysis revealed a sustained MCID reduction in SNOT-22 scores in both lung-transplanted and native lung groups, and in patients with primary ESS or previous ESS. However, there was no post-operative pulmonary function improvement in lung transplanted patients and patients with previous ESS. There was no impact on the rate of pulmonary exacerbations across the cohort. 2 patients in the cohort died secondary to pulmonary disease. CONCLUSIONS: There was a demonstrated clinical and symptomatic benefit of ESS in CF patients in this study. Stricter guidelines for indications for ESS need to be established with regards to CF patients who will undergo ESS in the future.

来源:Rhinology,查看原文。版权归原作者所有。

引用

  1. Devabalan Y, Towning R, Magill J, et al. Clinical outcomes of functional endoscopic sinus surgery in cystic fibrosis patients - a single centre experience. Rhinology. 2024. PMID: 38497762. doi:10.4193/Rhin23.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。